Evidence map›Paper›PMID 39668316›Full record

ArticleJournal of general internal medicine2025

The Implementation Climate for Integrating Buprenorphine Prescribing into Rural Primary Care.

Cheyenne Fenstemaker, Elizabeth A Abrams, Katherine King, Benjamin Obringer, Daniel L Brook, Vivian Go, William C Miller, Lindsay Y Dhanani, Berkeley Franz

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cheyenne FenstemakerOhio University Heritage College of Osteopathic Medicine, Institute to Advance Health Equity, Athens, OH, USA. fenstemaker@ohio.edu.ORCID 0000-0002-7150-5810
Elizabeth A AbramsThe Ohio State University College of Medicine, Columbus, OH, USA.
Katherine KingOhio University Heritage College of Osteopathic Medicine, Institute to Advance Health Equity, Athens, OH, USA.
Benjamin ObringerOhio University Heritage College of Osteopathic Medicine, Institute to Advance Health Equity, Athens, OH, USA.
Daniel L BrookDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Vivian GoGillings School of Public Health, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
William C MillerGillings School of Public Health, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
Lindsay Y DhananiSchool of Management and Labor Relations, Rutgers University, Piscataway, NJ, USA.
Berkeley FranzOhio University Heritage College of Osteopathic Medicine, Institute to Advance Health Equity, Athens, OH, USA.

Funding

Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing among Rural Primary Care Providers in OhioR34DA057160 · NIDA · OHIO UNIVERSITY ATHENS · PI FRANZ, BERKELEY · 2022 to 2024
$698k
NIDA NIH HHS R34 DA057160NIDA NIH HHS R34DA057160
6 · The paper itself

Abstract

backgroundRural communities have been significantly affected by opioid use disorder (OUD) and related harms but have less access to evidence-based medications for opioid use disorder (MOUD), such as buprenorphine. Given the shortage of specialists in these areas, rural primary care is an important setting to expand buprenorphine access, but implementation is limited.

objectiveTo explore implementation climate factors that support or hinder buprenorphine implementation in rural primary care.

designA qualitative study design using in-depth interviews.

participantsPrimary care physicians, nurse practitioners (NPs), and physician associates (PAs) practicing in rural Ohio counties. APPROACH: Between December 2022 and March 2023, we interviewed participants about their perspectives on buprenorphine prescribing, including using rural primary care as an implementation setting for buprenorphine. Using a deductive, framework-based approach, codes were grouped based on the Consolidated Framework for Implementation Research (CFIR) inner setting factors that contribute to a positive implementation climate for an intervention. KEY

resultsThree implementation climate constructs emerged as decision points for whether to implement buprenorphine in rural primary care: (1) relative priority: the extent to which OUD treatment should be prioritized over other chronic diseases; (2) compatibility: whether buprenorphine prescribing protocols are compatible with the rural primary care setting; (3) tension for change: the extent to which current buprenorphine access shortages in rural communities can be tolerated. Participants expressed mixed perspectives on whether the implementation climate in rural primary care currently supports buprenorphine prescribing.

conclusionImplementation strategies targeted toward the implementation climate are critical to support buprenorphine prescribing in rural primary care.

Indexed as

BuprenorphineDrug PrescriptionsNarcotic AntagonistsOpiate Substitution TreatmentOpioid-Related DisordersPractice Patterns, Physicians'Primary Health CareRural Health ServicesAdultFemaleHumansMaleMiddle AgedOhioQualitative ResearchRural PopulationBuprenorphineNarcotic Antagonistsaddiction medicine; rural; rural healthbuprenorphineimplementationopioid-related disordersprimary care

Identifiers

PMID39668316
PMCPMC12434468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.